Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis

Fig. 1

ZNF703 expression in breast cancer. A Immunoblotting (IB) for ZNF703 in total cell lysates from five triple-negative breast cancer (TNBC) cell lines (red circles), two normal breast epithelial cell lines MCF-10 A, HBL-100 (green circles) and representative examples of other breast cancer subtypes (yellow circles for luminal-type, and blue circles for HER2-positive subtype). A GAPDH antibody was used as a loading control. B Representative image of IHC staining for ZNF703 in TNBC specimens. Left: low ZNF703 expression; Right: high ZNF703 expression. The bar represents 50 μm. C Immunostaining scores of ZNF703 in 76 TNBC patients. The vertical axis indicates the differences between the score of each patient and the median score. High expression group was indicated as positive numbers, and low/no expression group was indicated as zero or negative numbers

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us